Ignite Creation Date:
2024-05-06 @ 8:51 AM
Last Modification Date:
2024-10-26 @ 12:05 PM
Study NCT ID:
NCT02831673
Status:
COMPLETED
Last Update Posted:
2023-08-24
First Post:
2016-07-08
Brief Title:
An Efficacy Safety and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus TenofovirEmtricitabine in Treatment naïve HIV Infected Subjects Gemini 1
Sponsor:
ViiV Healthcare
Organization:
ViiV Healthcare